Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 5401-5450 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT05989269
Diagnostic Stewardship for Ventilator Associated Pneumonia
NA
Active, not recruiting
400 participants
Started: Aug 21, 2023 · Completed: Sep 30, 2025
1 condition
5 sponsors
3 locations
NCT05058157
Ketone Plasma Kinetics After Oral Intake of Different Ketogenic Formulae
NA
Active, not recruiting
20 participants
Started: Aug 21, 2023 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT05698199
Study to Evaluate the Safety, Tolerability, Immunogenicity and Preliminary Efficacy of ITI-1001 In Patients With Newly Diagnosed Glioblastoma (GBM)
PHASE1
Active, not recruiting
10 participants
Started: Aug 21, 2023 · Completed: Mar 31, 2026
1 condition
1 sponsor
1 location
NCT05935098
BGB-A3055 Alone and in Combination With Tislelizumab in Participants With Solid Tumors
PHASE1
Active, not recruiting
263 participants
Started: Aug 21, 2023 · Completed: Mar 31, 2027
3 conditions
1 sponsor
26 locations
NCT05845866
Targeting Weight and Shape Concern Among Women with High Body Weight
NA
Active, not recruiting
60 participants
Started: Aug 21, 2023 · Completed: Aug 31, 2025
3 conditions
2 sponsors
1 location
NCT06714812
Diarrheal Adverse Events in Caucasian Patients With Idiopathic Pulmonary Fibrosis Undergoing Treatment With Nintedanib
N/A
Active, not recruiting
100 participants
Started: Aug 20, 2023 · Completed: Oct 31, 2025
1 condition
1 sponsor
1 location
NCT06769035
Effect of a Food Supplement with Natural Extracts of Cocoa, Amaranth Seed and Ginger in Overweight or Obese Patients
NA
Active, not recruiting
40 participants
Started: Aug 20, 2023 · Completed: Jun 30, 2025
3 conditions
1 sponsor
1 location
NCT06259851
rTMS-enhanced Psychotherapy for Borderline Personality Disorder
NA
Active, not recruiting
60 participants
Started: Aug 20, 2023 · Completed: Dec 31, 2026
1 condition
3 sponsors
1 location
NCT07116252
Effect of Different Irrigation Protocols on Postoperative Endodontic Pain and Inflammation
NA
Active, not recruiting
75 participants
Started: Aug 20, 2023 · Completed: Dec 31, 2025
4 conditions
1 sponsor
1 location
NCT06018883
Vitamin C to Chemotherapy Related Anemia in Pancreatic Cancer
PHASE3
Active, not recruiting
100 participants
Started: Aug 20, 2023 · Completed: Aug 15, 2026
1 condition
1 sponsor
1 location
NCT06410040
A Retrospective Study of the Efficacy and Safety of Lolatinib in ALK+ NSCLC Patients With Brain or Meningeal Metastasis
N/A
Active, not recruiting
28 participants
Started: Aug 20, 2023 · Completed: Jun 30, 2024
3 conditions
1 sponsor
1 location
NCT06007209
Blind Vs US Guided Manual Pressure Points
NA
Active, not recruiting
66 participants
Started: Aug 20, 2023 · Completed: Nov 30, 2025
2 conditions
2 sponsors
1 location
NCT05843045
Indoor Air Quality Asthma Study: The Effect of Indoor Air Quality and Mitigation of Same on Persistent Asthma
NA
Active, not recruiting
10 participants
Started: Aug 18, 2023 · Completed: Jan 12, 2026
1 condition
3 sponsors
1 location
NCT05949190
Improving Cognition and Gestational Duration With Targeted Nutrition
NA
Active, not recruiting
1,600 participants
Started: Aug 18, 2023 · Completed: Sep 30, 2026
5 conditions
5 sponsors
10 locations
NCT06056128
Confirmation of Accuracy of the Tool-in-lesion Technology (TiLT) of the Galaxy System With Integrated TOMO Technology
NA
Active, not recruiting
25 participants
Started: Aug 18, 2023 · Completed: Apr 30, 2025
2 conditions
1 sponsor
1 location
NCT03348670
Pharmacogenomics IND Commercial SNP Clinical Study - Abiraterone and Single Nucleotide Polymorphisms
PHASE2/PHASE3
Active, not recruiting
600 participants
Started: Aug 18, 2023 · Completed: May 28, 2026
1 condition
1 sponsor
1 location
NCT05704634
A Phase Ib Study to Evaluate the Safety and Preliminary Efficacy of IL6-receptor Antibody Sarilumab in Combination With antiPD1 Antibody Cemiplimab for Patients With Non-small Cell Lung Cancer.
PHASE1
Active, not recruiting
56 participants
Started: Aug 18, 2023 · Completed: Jan 1, 2028
1 condition
2 sponsors
1 location
NCT03529448
TN-TC11G (THC+CBD) Combination With Temozolomide and Radiotherapy in Patients With Newly-diagnosed Glioblastoma
PHASE1/PHASE2
Active, not recruiting
33 participants
Started: Aug 18, 2023 · Completed: Dec 31, 2025
1 condition
4 sponsors
8 locations
NCT05978037
A Study to Assess the Safety and Effectiveness of Two Experimental Malaria Vaccines
PHASE1/PHASE2
Active, not recruiting
58 participants
Started: Aug 18, 2023 · Completed: Mar 10, 2026
5 conditions
1 sponsor
1 location
NCT05959083
Real World Study of Oral Upadacitinib Tablets to Assess Adverse Events and Change in Disease Activity in Adolescent and Adult Chinese Participants With Atopic Dermatitis
N/A
Active, not recruiting
200 participants
Started: Aug 18, 2023 · Completed: Jun 30, 2026
1 condition
1 sponsor
18 locations
NCT06149169
CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Large B-cell Lymphoma
PHASE2
Active, not recruiting
10 participants
Started: Aug 17, 2023 · Completed: Mar 31, 2025
2 conditions
1 sponsor
1 location
NCT06971081
LED Application Following Dental Extraction in Patients Taking Direct Oral Anticoagulants.
NA
Active, not recruiting
50 participants
Started: Aug 17, 2023 · Completed: Jun 30, 2025
1 condition
1 sponsor
1 location
NCT05570916
Zip-Stitch® in Minimally-Invasive Surgery (ZIMS) - Safety & Efficacy in Hysterectomy
NA
Active, not recruiting
59 participants
Started: Aug 17, 2023 · Completed: May 10, 2025
1 condition
2 sponsors
5 locations
NCT05981131
Follow up of Intravesical N-803 Plus BCG in BCG-Naive Non-Muscle Invasive Bladder Cancer (NMIBC)
N/A
Active, not recruiting
6 participants
Started: Aug 17, 2023 · Completed: Aug 30, 2033
1 condition
1 sponsor
1 location
NCT05840016
AK112 in Combination With Chemotherapy in Advanced Squamous Non-Small Cell Lung Cancer
PHASE3
Active, not recruiting
532 participants
Started: Aug 17, 2023 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT05996471
A Study to Investigate the Virologic Efficacy and Safety of VH3810109 + Cabotegravir Compared to Standard of Care (SOC) in Male and Female Adults Living With Human Immunodeficiency Virus (HIV)
PHASE2
Active, not recruiting
128 participants
Started: Aug 17, 2023 · Completed: Jan 17, 2029
1 condition
1 sponsor
45 locations
NCT05705427
The COMBAT HBV Feasibility Trial
PHASE4
Active, not recruiting
317 participants
Started: Aug 17, 2023 · Completed: Dec 31, 2025
2 conditions
5 sponsors
1 location
NCT05898022
Pragmatic Research on Diuretic Management in Early BPD Pilot
PHASE4
Active, not recruiting
30 participants
Started: Aug 17, 2023 · Completed: Dec 31, 2025
1 condition
5 sponsors
4 locations
NCT05907304
A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With RAS Q61X Mutations
PHASE1
Active, not recruiting
86 participants
Started: Aug 17, 2023 · Completed: Nov 30, 2025
1 condition
1 sponsor
29 locations
NCT04586660
Study of XGEVA® (Denosumab) in Chinese Adults and Skeletally Mature Adolescents With Giant Cell Tumor of the Bone
PHASE4
Active, not recruiting
36 participants
Started: Aug 17, 2023 · Completed: Mar 7, 2028
1 condition
1 sponsor
10 locations
NCT05710406
Testing the Use of BRAF-Targeted Therapy After Surgery and Usual Chemotherapy for BRAF-Mutated Colon Cancer
PHASE2/PHASE3
Active, not recruiting
1 participants
Started: Aug 16, 2023 · Completed: Jun 1, 2034
5 conditions
2 sponsors
202 locations
NCT06058429
Immunogenicity of After Primary Immunization and Booster Immunization of sIPV
N/A
Active, not recruiting
233 participants
Started: Aug 16, 2023 · Completed: Dec 31, 2023
1 condition
2 sponsors
1 location
NCT06892561
Phase-Aligned Atrial Fibrillation Mapping
N/A
Active, not recruiting
320 participants
Started: Aug 16, 2023 · Completed: Aug 16, 2026
1 condition
1 sponsor
1 location
NCT06858618
FCN-338 in Combination With Azacitidine or Chemotherapy in Myeloid Neoplasms
PHASE2
Active, not recruiting
47 participants
Started: Aug 16, 2023 · Completed: Dec 31, 2026
3 conditions
2 sponsors
1 location
NCT06021522
A Study to Evaluate Long-term Safety of Ecopipam Tablets in Children, Adolescents and Adults With Tourette's Disorder
PHASE3
Active, not recruiting
150 participants
Started: Aug 16, 2023 · Completed: Mar 31, 2027
1 condition
1 sponsor
67 locations
NCT05771480
Durvalumab With Chemotherapy as First Line Treatment in Patients With Advanced Biliary Tract Cancers (aBTCs)
PHASE3
Active, not recruiting
142 participants
Started: Aug 16, 2023 · Completed: Mar 17, 2026
1 condition
1 sponsor
34 locations
NCT05944978
A Study of GNC-035 in Relapsed or Refractory Chronic Lymphocytic Leukemia and Other Hematological Malignancies
PHASE1/PHASE2
Active, not recruiting
3 participants
Started: Aug 16, 2023 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05885555
A Study of Ianalumab (VAY736) in Patients With Primary Immune Thrombocytopenia (ITP) Previously Treated With at Least Two Lines of Therapies
PHASE2
Active, not recruiting
41 participants
Started: Aug 16, 2023 · Completed: Mar 19, 2029
1 condition
1 sponsor
24 locations
NCT05558982
BXCL701 and Pembrolizumab in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
PHASE2
Active, not recruiting
22 participants
Started: Aug 16, 2023 · Completed: Nov 30, 2027
1 condition
3 sponsors
3 locations
NCT05949645
Study to Assess Safety, Feasibility, and Preliminary Efficacy of the Apreo Implant for Severe Emphysema
NA
Active, not recruiting
30 participants
Started: Aug 15, 2023 · Completed: Jun 1, 2026
1 condition
1 sponsor
3 locations
NCT05957432
Efficacy and Safety of Black Seed Oil With Vonoprazan Based Triple Therapy in Treatment of Helicobacter Pylori
PHASE2
Active, not recruiting
90 participants
Started: Aug 15, 2023 · Completed: Nov 30, 2025
1 condition
1 sponsor
1 location
NCT05980130
Can Rumination-Focused Cognitive Behavioral Therapy Reduce the Risk of Cardio-vascular Disease?
NA
Active, not recruiting
9 participants
Started: Aug 15, 2023 · Completed: Aug 31, 2025
3 conditions
1 sponsor
1 location
NCT05969730
Baricitinib Versus Azathioprine in Patients With Moderate-to-Severe Atopic Dermatitis
NA
Active, not recruiting
40 participants
Started: Aug 15, 2023 · Completed: Jun 30, 2025
1 condition
1 sponsor
1 location
NCT06160102
Safe Drug Use in People With Intellectual and/or Developmental Disabilities - it Applies to Life
NA
Active, not recruiting
110 participants
Started: Aug 15, 2023 · Completed: Jul 31, 2027
2 conditions
3 sponsors
1 location
NCT04194424
A Multidisciplinary Weight Loss Program at AUB-MC
NA
Active, not recruiting
20 participants
Started: Aug 15, 2023 · Completed: Sep 15, 2026
2 conditions
1 sponsor
1 location
NCT05943678
Novel Metabolic Muscular Biomarkers in Pompe Disease - a Non-invasive Magnetic Resonance Exploratory Pilot Study.
N/A
Active, not recruiting
30 participants
Started: Aug 15, 2023 · Completed: Oct 15, 2028
2 conditions
1 sponsor
1 location
NCT06199362
Early Life Anemia and Children's Risk of Neurodevelopmental Disorders: National and Regional Register-based Studies
N/A
Active, not recruiting
2,400,000 participants
Started: Aug 15, 2023 · Completed: Dec 31, 2024
5 conditions
2 sponsors
1 location
NCT06697977
Effects of Phytosterol Supplementation on Liver Function and Inflammatory Status in Patients with Nonalcoholic Fatty Liver Disease
NA
Active, not recruiting
28 participants
Started: Aug 15, 2023 · Completed: Feb 28, 2025
7 conditions
1 sponsor
1 location
NCT06076356
Effects of Foam Roller Versus KT Tape on Delayed Onset Muscle Soreness
NA
Active, not recruiting
24 participants
Started: Aug 15, 2023 · Completed: Jan 31, 2024
1 condition
1 sponsor
1 location
NCT06014736
A Phase I Study of XJ101 in Chinese Healthy Subjects
PHASE1
Active, not recruiting
38 participants
Started: Aug 15, 2023 · Completed: Sep 1, 2024
1 condition
1 sponsor
1 location
Previous
1
More pages
106
107
108
109
110
111
112
More pages
431
Next